KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION DIN 02329794
Status: Marketed
Holder: CURIUM CANADA INC
Health Canada record
| Active ingredient(s) | TETRAKIS [CU(MIBI)4]BF4 1 MG |
|---|
| Dosage form | Kit; Powder For Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | SCHEDULE C |
|---|
| Class | Radiopharmaceutical |
|---|
| ATC | V09GA01 TECHNETIUM (99m Tc) SESTAMIBI |
|---|
| Original market date | 02-Dec-2019 |
|---|
| Current status date | 02-Dec-2019 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Curium Canada Inc. — licence 3-002566, currently licensed, last inspection rating C (2026-07-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TETRAKIS [CU(MIBI)4]BF4
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02328003 | CARDIOLITE | LANTHEUS MI CANADA INC | Powder For Solution | TETRAKIS [CU(MIBI)4]BF4 1 MG | Marketed |
| 02327732 | DRAXIMAGE SESTAMIBI | JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA | Powder For Solution | TETRAKIS [CU(MIBI)4]BF4 1 MG | Marketed |
| 02327929 | MIRALUMA | LANTHEUS MI CANADA INC | Powder For Solution | TETRAKIS [CU(MIBI)4]BF4 1 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 28722 | 2019-06-28 | Abbreviated New Drug Submission (ANDS) | Administrative ¿ Manufacturer Name Change; Labelling updates |
Request a quote for KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
How to read a Canadian DIN record